| Gallbladder and Bile Duct Disorders | Lifetime | 211 | IT 17 | 98.93 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 438 | IT 30 | 98.88 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 321 | IT 31 | 98.88 |
| Pancreatitis Pathology and Treatment | Lifetime | 276 | IT 21 | 98.54 |
| Gastric Cancer Management and Outcomes | Lifetime | 526 | IT 29 | 98.87 |
| Liver Disease Diagnosis and Treatment | Lifetime | 989 | IT 88 | 98.80 |
| Colorectal Cancer Screening and Detection | Lifetime | 471 | IT 28 | 98.22 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 423 | IT 23 | 97.70 |
| Liver Disease and Transplantation | Lifetime | 859 | IT 72 | 98.00 |
| Cancer Mechanisms and Therapy | Lifetime | 349 | IT 17 | 96.47 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 491 | IT 31 | 93.31 |
| Hemostasis and retained surgical items | Lifetime | 936 | IT 34 | 74.01 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 1 | IT 1 | 99.87 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 6 | IT 1 | 99.85 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 5 | IT 1 | 99.72 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 10 | IT 3 | 99.66 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 26 | IT 6 | 99.67 |
| Esophageal and GI Pathology | 2021-2025 | 30 | IT 5 | 99.17 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 23 | IT 8 | 98.71 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 39 | IT 2 | 98.45 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 121 | IT 28 | 96.76 |
| Gastrointestinal Bleeding Diagnosis and Treatment | 2021-2025 | 29 | IT 5 | 95.92 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 590 | IT 57 | 97.40 |
| Biliary and Gastrointestinal Fistulas | 2021-2025 | 25 | IT 9 | 95.20 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 284 | IT 38 | 96.80 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 240 | IT 32 | 95.60 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 269 | IT 10 | 94.91 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 998 | IT 85 | 94.52 |
| Gastroesophageal reflux and treatments | 2021-2025 | 154 | IT 16 | 94.07 |
| Gastrointestinal disorders and treatments | 2021-2025 | 241 | IT 22 | 92.15 |
| Liver Disease and Transplantation | 2021-2025 | 571 | IT 66 | 94.79 |
| Diverticular Disease and Complications | 2021-2025 | 267 | IT 50 | 87.45 |
| Lung Cancer Research Studies | 2021-2025 | 899 | IT 76 | 90.27 |
| Colorectal Cancer Surgical Treatments | 2021-2025 | 872 | IT 95 | 89.17 |
| Genetic factors in colorectal cancer | 2021-2025 | 966 | IT 104 | 85.72 |
| Cancer Mechanisms and Therapy | 2021-2025 | 431 | IT 20 | 82.43 |
| Microscopic Colitis | 2021-2025 | 917 | IT 108 | 86.43 |
| Metastasis and carcinoma case studies | 2021-2025 | 640 | IT 31 | 81.76 |
| Bariatric Surgery and Outcomes | 2021-2025 | 814 | IT 55 | 82.97 |
| Hemostasis and retained surgical items | 2021-2025 | 168 | IT 3 | 70.85 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 745 | IT 56 | 71.06 |
| Foreign Body Medical Cases | 2021-2025 | 167 | IT 15 | 66.95 |
| Abdominal Trauma and Injuries | 2021-2025 | 666 | IT 39 | 60.13 |
| Intestinal and Peritoneal Adhesions | 2021-2025 | 719 | IT 56 | 55.26 |
| Medical Device Sterilization and Disinfection | 2021-2025 | 277 | IT 26 | 56.15 |
| Porphyrin Metabolism and Disorders | 2021-2025 | 858 | IT 50 | 26.73 |
